XellSmart Achieves Fourth Consecutive Regulatory Approval for Breakthrough Cell Therapy for MSA-P #China #Suzhou #XellSmart #iPSC_therapy #MSA-P
1
0
0
0
XellSmart Achieves Fourth Consecutive Regulatory Approval for Breakthrough Cell Therapy for MSA-P #China #Suzhou #XellSmart #iPSC_therapy #MSA-P
BrainXell Unveils Groundbreaking Research on iPSC Therapy at 2025 SfN Meeting #United_States #San_Diego #iPSC_therapy #BrainXell #BXT-110
XellSmart's Breakthrough Spinocord Injury Therapy Achieves FDA Approval for Clinical Trials #China #Suzhou #Spinal_Cord_Injury #XellSmart #iPSC_therapy